SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : CyberCash a buy? -- Ignore unavailable to you. Want to Upgrade?

To: Jeff G. who wrote (1673)7/1/1998 11:36:00 PM
From: calvis  Respond to of 3990
 
The key is a hostile takeover. That is what they are defending themselves against. With CYCH at such a low price it might be tempting for a financial Corp. to make a cash tender offer. With the poison pill in place the buyer must make a favorable offer that pleases management. This should in the long run increase shareholder value. This is how I see it.

Later,

Charles



To: Jeff G. who wrote (1673)7/2/1998 8:20:00 AM
From: Lee  Read Replies (1) | Respond to of 3990
 
Jeff,

Another way to look at it is that management does not see CYCH as fairly valued at this price, hence the poison pill.

In any event, you should own this stock if your DD and own thoughts conclude you'll make more money here than in other opps available to you.

Regards,
Lee


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News